US Bancorp’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-54
Closed -$242 – 4265
2026
Q2
$242 Sell
54
-105
-66% -$785 ﹤0.01% 4098
2026
Q1
$1.67K Sell
159
-110
-41% -$1.07K ﹤0.01% 3842
2025
Q4
$3.1K Sell
269
-71
-21% -$1.1K ﹤0.01% 3665
2025
Q3
$8.27K Hold
340
– – ﹤0.01% 3377
2025
Q2
$5.6K Buy
340
+71
+26% +$1.23K ﹤0.01% 3608
2025
Q1
$4.9K Sell
269
-421
-61% -$12K ﹤0.01% 3666
2024
Q4
$25.6K Buy
690
+169
+32% +$6.47K ﹤0.01% 3057
2024
Q3
$16.7K Buy
+521
New +$28.9K ﹤0.01% 3191
2023
Q4
– Sell
-9
Closed -$1.45K – 3995
2023
Q3
$1.45K Buy
+9
New +$1.17K ﹤0.01% 3712
2022
Q4
– Sell
-32
Closed -$3K – 4154
2022
Q3
$3K Sell
32
-8
-20% -$1.14K ﹤0.01% 3717
2022
Q2
$9K Buy
40
+36
+900% +$12.1K ﹤0.01% 3385
2022
Q1
$2K Sell
4
-2
-33% -$1.21K ﹤0.01% 3805
2021
Q4
$4K Sell
6
-21
-78% -$16.1K ﹤0.01% 3698
2021
Q3
$23K Buy
27
+3
+13% +$3.04K ﹤0.01% 3054
2021
Q2
$31K Buy
24
+17
+243% +$19.2K ﹤0.01% 2901
2021
Q1
$8K Sell
7
-2
-22% -$2.64K ﹤0.01% 3355
2020
Q4
$13K Buy
9
+1
+13% +$1.07K ﹤0.01% 3078
2020
Q3
$6K Buy
8
+6
+300% +$4.36K ﹤0.01% 3223
2020
Q2
$1K Buy
+2
New +$1.16K ﹤0.01% 3580

Other funds holding CDLX

US Bancorp's CDLX Position: Q3 2026 in Review

US Bancorp sold out of Cardlytics (CDLX) in Q3 2026, closing a stake of 54 shares — an estimated $242 sold.

US Bancorp first reported a position in CDLX in Q2 2020 and held it in 19 quarters. The position peaked at $31K in Q2 2021. 9 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.

  • US Bancorp reported no remaining Cardlytics position as of Q3 2026 after selling out during the quarter.
  • US Bancorp sold 54 Cardlytics shares in Q3 2026, an estimated $242.
  • US Bancorp first reported a position in Cardlytics in Q2 2020 and held it in 19 quarters.
  • US Bancorp's Cardlytics position peaked at $31K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.